Aigen Investment Management, LP Prothena Corp Public LTD CO Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$24.75 - $40.66 $245,049 - $402,574
9,901 New
9,901 $245,000
Q3 2023

Nov 13, 2023
BUY
$47.3 - $70.6 $1.65 Million - $2.46 Million
34,890 New
34,890 $1.68 Million
Q1 2023

May 15, 2023
BUY
$46.97 - $58.27 $305,445 - $378,929
6,503 New
6,503 $315,000
Q4 2020

Feb 12, 2021
SELL
$10.12 - $13.94 $133,148 - $183,408
-13,157 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$9.93 - $13.47 $130,649 - $177,224
13,157 New
13,157 $131,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email